Celsion Corp at Chardan Genetic Medicines Conference (Virtual) Transcript
Hi, everyone, and thank you for joining us at Chardan's Fifth Annual Genetic Medicines Conference. My name is Daniil Gataulin; I am a Senior Biotech Associate at Chardan. It is my pleasure to introduce our next presenting guests from Celsion, Michael Tardugno, Chairman and CEO and Dr. Khursheed Anwer, Chief Scientific Officer. The format for this session is a fireside chat. I encourage the members of the audience to ask questions. (Conference Instructions). And with that, I can get right into it.
Questions & Answers
To begin, Michael, if you could give us a few minutes overview of Celsion and perhaps highlight recent accomplishments.
Sure. Well, first, thank you for inviting us to the conference today. We are delighted to be here. Chardan always provides a terrific conference for both the presenters and the investment community.
Celsion is a clinical-stage
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
